Recommendations on the use of a first booster dose of Pfizer-BioNTech Comirnaty COVID-19 vaccine in children 5 to 11 years of age. : HP5-141/1-2022E-PDF ; HP5-141/2-2022E-PDF
Lien permanent pour cette publication :
publications.gc.ca/pub?id=9.914493&sl=1
| Ministère/Organisme | Public Health Agency of Canada, issuing body. |
|---|---|
| Titre | Recommendations on the use of a first booster dose of Pfizer-BioNTech Comirnaty COVID-19 vaccine in children 5 to 11 years of age. |
| Type de publication | Monographie |
| Langue | [Anglais] |
| Autres langues publiées | [Français] |
| Édition ultérieure | Updated recommendations on the use of COVID-19 vaccine booster doses in children 5 to 11 years of age and concurrent vaccine administration. |
| Format | Électronique |
| Document électronique |
|
| Note(s) | Issued also in French under title: Recommandations sur l'utilisation d'une première dose de rappel du vaccin Comirnaty de Pfizer-BioNTech contre la COVID-19 chez les les enfants de 5 à 11 ans. At head of title: An Advisory Committee Statement (ACS), National Advisory Committee on Immunization (NACI). Includes bibliographical references (pages 14-17). |
| Information sur la publication | Ottawa, ON : Public Health Agency of Canada = Agence de la santé publique du Canada, August 19, 2022. ©2022 |
| Description | 1 online resource (17 pages) + 1 summary (5 pages) |
| ISBN | 9780660450681 9780660450698 |
| Numéro de catalogue |
|
| Numéro de catalogue du ministère | 220374 (report) 220376 (summary) |
| Descripteurs | COVID-19 vaccines -- Canada. COVID-19 (Disease) -- Vaccination -- Canada. Vaccination of children -- Canada. COVID-19 vaccines -- Government policy -- Canada. COVID-19 (Disease) -- Vaccination -- Government policy -- Canada. Vaccination of children -- Government policy -- Canada. |